| 國立成功大學 |
2023 |
Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
|
Chen, P.-C.;Lee, K.-H.;Lee, W.-C.;Yeh, T.-C.;Kuo, Y.-C.;Chiang, B.-J.;Liao, C.-H.;Meng, E.;Kao, Y.-L.;Lee, Y.-C.;Kuo, H.-C. |
| 國立成功大學 |
2023 |
Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment
|
Kao, Y.-L.;Chen, J.-T.;Chen, S.-L.;Shao, I.-H.;Wang, C.-C.;Chiang, I.-N.;Hsu, Y.-C.;Lee, K.-H.;Lee, W.-C.;Yeh, T.-C.;Kuo, Y.-C.;Chiang, B.-J.;Liao, C.-H.;Chen, P.-C.;Meng, E.;Lee, Y.-C.;Kuo, H.-C. |
| 國立成功大學 |
2023 |
Psychological Toll of the COVID-19 Pandemic: An In-Depth Exploration of Anxiety, Depression, and Insomnia and the Influence of Quarantine Measures on Daily Life
|
Aljaberi, M.A.;Al-Sharafi, M.A.;Uzir, M.U.H.;Sabah, A.;Ali, Ali A.M.;Lee, K.-H.;Alsalahi, Alsalahi A.;Noman, S.;Lin, C.-Y. |
| 國立成功大學 |
2023 |
Validity and Reliability of a Questionnaire on the Knowledge, Attitudes, Perceptions and Practices toward Food Poisoning among Malaysian Secondary School Students: A Pilot Study
|
Ramu, P.;Osman, M.;Abdul, Mutalib N.A.;Aljaberi, M.A.;Lee, K.-H.;Lin, C.-Y.;Hamat, R.A. |
| 國立成功大學 |
2023 |
Psychometric Properties of the Perceived Collective Family Efficacy Scale in Algeria
|
Sabah, A.;Aljaberi, M.A.;Lee, K.-H.;Lin, C.-Y. |
| 國立成功大學 |
2023 |
Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
|
Lin, C.-H.;Lin, W.-D.;Huang, Y.-C.;Chen, Y.-C.;Loh, Z.-J.;Ger, L.-P.;Lin, F.-C.;Li, H.-Y.;Cheng, H.-C.;Lee, K.-H.;Hsiao, M.;Lu, P.-J. |
| 國立成功大學 |
2023 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, L.V.;Yang, J.C.-H.;Yamamoto, N.;O'Byrne, K.;Hirsh, V.;Mok, T.;Geater, S.L.;Orlov, S.;Tsai, C.-M.;Boyer, M.;Su, W.-C.;Bennouna, J.;Kato, T.;Gorbunova, V.;Lee, K.H.;Shah, R.;Massey, D.;Zazulina, V.;Shahidi, M.;Schuler, M. |
| 國立成功大學 |
2023 |
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
|
Tsuboi, M.;Herbst, R.S.;John, T.;Kato, T.;Majem, Majem M.;Groh�, C.;Wang, J.;Goldman, J.W.;Lu, S.;Su, W.-C.;De, Marinis F.;Shepherd, F.A.;Lee, K.H.;Le, N.T.;Dechaphunkul, A.;Kowalski, D.;Poole, L.;Bolanos, A.;Rukazenkov, Y.;Wu, Y.-L. |
| 臺大學術典藏 |
2022-09-15T01:08:56Z |
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
|
Desai J.; Deva S.; Lee J.S.; Chia-Chi Lin; Yen C.-J.; Chao Y.; Keam B.; Jameson M.; Hou M.-M.; Kang Y.-K.; Markman B.; Lu C.-H.; Rau K.-M.; Lee K.-H.; Horvath L.; Friedlander M.; Hill A.; Sandhu S.; Barlow P.; Wu C.-Y.; Zhang Y.; Liang L.; Wu J.; Paton V.; Millward M. |
| 臺大學術典藏 |
2022-09-15T01:08:55Z |
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
|
Paz-Ares L.; Kim T.M.; Vicente D.; Felip E.; Lee D.H.; Lee K.H.; Chia-Chi Lin; Flor M.J.; Di Nicola M.; Alvarez R.M.; Dussault I.; Helwig C.; Ojalvo L.S.; Gulley J.L.; Cho B.C. |
| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park K.; Tan D.S.W.; Su W.-C.; Cho B.C.; Kim S.-W.; Lee K.H.; Wang C.-C.; Seto T.; Huang D.C.-L.; Jung H.H.; Hsu M.-C.; Bogenrieder T.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Hsu C.-H.; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.; Chao Y.; Chen J.-S.; Bang Y.-J.; Bendell J.; Lee K.-H.; Wang Y.; Abdullah H.; Liu B.; Spahn J.; Hack S.P.; Verret W.; CHIH-HUNG HSU; Lee M.S. |
| 臺大學術典藏 |
2022-08-19T00:20:33Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Tebbutt N.; Strickler J.; Stein S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Dev A.; Davis S.L.; Chung H.C.; Chen J.-S.; Chao Y.; Bendell J.; Bang Y.-J.; Lee K.-H.; He A.R.; Wang Y.; Liu B.; Abdullah H.; Hack S.P.; Spahn J.; Lee M.S.; Ryoo B.-Y.; Hsu C.-H.; Numata K.; Stein S.; Verret W. |
| 臺大學術典藏 |
2022-08-10T02:37:39Z |
Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study
|
Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C. |
| 臺大學術典藏 |
2022-08-10T02:37:38Z |
Brigatinib Versus Crizotinib in ALK Inhibitor�VNaive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
|
Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garcia Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.I.; Gettinger S.N.; Tiseo M.; Lin H.M.; Liu Y.; Vranceanu F.; Niu H.; Zhang P.; Popat S. |
| 臺大學術典藏 |
2022-08-09T03:50:57Z |
Electronic and atomic structures of Si-C-N thin film by X-ray-absorption spectroscopy
|
Pong W.F.; Chang Y.K.; Hsieh H.H.; Tsai M.-H.; Lee K.H.; Dann T.E.; Chien F.Z.; Tseng P.K.; Tsang K.L.; Su W.K.; Chen L.C.; Wei S.L.; Chen K.H.; Bhusari D.M.; Chen Y.F.; Pong W.F.; Chen L.C.; Wei S.L.; Chen Y.F.; LI-CHYONG CHEN |
| 臺大學術典藏 |
2022-07-12T01:43:01Z |
Sexual and bladder dysfunction in male ketamine abusers: A large-scale questionnaire study
|
Yang S.S.-D.; Jang M.-Y.; Lee K.-H.; Hsu W.-T.; Chen Y.-C.; Chen W.-S.; SHANG-JEN CHANG |
| 臺大學術典藏 |
2022-05-13T02:40:47Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; Wu V.-C.; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; Wu V.-C.; Lai T.-S.; Lin Y.-F.; Tsai I.-J.; Lai C.-F.; TAO-MIN HUANG; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2022-05-11T08:25:41Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN; Lu Y.-S.; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. |
| 臺大學術典藏 |
2022-04-28T12:31:42Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; Wu V.-C.; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; Huang T.-M.; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs); KUO-LIONG CHIEN |
| 臺大學術典藏 |
2022-04-25T03:57:24Z |
Connecting MHC-I-binding motifs with HLA alleles via deep learning
|
Lee K.-H;Chang Y.-C;Chen T.-F;Juan H.-F;Tsai H.-K;Chen C.-Y.; Lee K.-H; Chang Y.-C; Chen T.-F; Juan H.-F; Tsai H.-K; Chen C.-Y.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2022-03-31T09:03:41Z |
Transgenerational effects of di(2-ethylhexyl) phthalate on anogenital distance, sperm functions and dna methylation in rat offspring
|
Hsu P.-C.; Jhong J.-Y.; Huang L.-P.; Lee K.-H.; Chen H.-P.; YUE-LIANG GUO |
| 臺大學術典藏 |
2022-03-29T07:00:02Z |
Intra-Colonial Functional Differentiation-Related Modulation of the Cellular Membrane in a Pocilloporid Coral Seriatopora caliendrum
|
Tang C.-H.; Ku P.-C.; CHING-YU LIN; Chen T.-H.; Lee K.-H.; Lee S.-H.; Wang W.-H. |
| 臺大學術典藏 |
2022-03-14T12:48:22Z |
QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells
|
Chen M.-C.; Pan S.-L.; Shi Q.; Xiao Z.; Lee K.-H.; TSAI-KUN LI; Teng C.-M. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial
|
Kudo M.; Lim H.Y.; ANN-LII CHENG; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. |
| 國立成功大學 |
2022 |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts
|
Tsai, Y.-T.;Li, C.-Y.;Huang, Y.-H.;Chang, T.-S.;Lin, C.-Y.;Chuang, Chuang C.-H.;Wang, C.-Y.;Anuraga, G.;Chang, T.-H.;Shih, T.-C.;Lin, Z.-Y.;Chen, Y.-L.;Chung, I.;Lee, K.-H.;Chang, Chang C.-C.;Sung, Sung S.-Y.;Yang, K.-H.;Tsui, W.-L.;Yap, C.-V.;Wu, M.-H. |
| 國立成功大學 |
2022 |
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
|
Chan, S.L.;Schuler, M.;Kang, Y.-K.;Yen, C.-J.;Edeline, J.;Choo, S.P.;Lin, C.-C.;Okusaka, T.;Weiss, K.-H.;Macarulla, T.;Cattan, S.;Blanc, J.-F.;Lee, K.-H.;Maur, Maur M.;Pant, S.;Kudo, M.;Assenat, E.;Zhu, A.X.;Yau, T.;Lim, H.Y.;Bruix, J.;Geier, A.;Guill�n-Ponce, C.;Fasolo, A.;Finn, R.S.;Fan, J.;Vogel, A.;Qin, S.;Riester, M.;Katsanou, V.;Chaudhari, M.;Kakizume, T.;Gu, Y.;Porta, D.G.;Myers, A.;Delord, J.-P. |
| 國立成功大學 |
2022 |
Rasch Modeling and Multilevel Confirmatory Factor Analysis for the Usability of the Impact of Event Scale-Revised (IES-R) during the COVID-19 Pandemic
|
Aljaberi, M.A.;Lee, K.-H.;Alareqe, N.A.;Qasem, M.A.;Alsalahi, Alsalahi A.;Abdallah, Abdallah A.M.;Noman, S.;Al-Tammemi, Al-Tammemi A.B.;Mohamed, Ibrahim M.I.;Lin, C.-Y. |
| 國立成功大學 |
2022 |
Nephrotoxins and acute kidney injury – The consensus of the Taiwan acute kidney injury Task Force
|
Huang, W.-C.;Wang, M.-T.;Lai, T.-S.;Lee, K.-H.;Shao, Shao S.-C.;Chen, Chen C.-H.;Su, C.-H.;Chen, Y.-T.;Sung, J.-M.;Chen, Y.-C. |
| 臺大學術典藏 |
2021-11-30T04:53:53Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; VIN-CENT WU; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; Huang T.-M.; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) |
| 臺大學術典藏 |
2021-11-30T04:53:40Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; VIN-CENT WU; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; VIN-CENT WU; Lai T.-S.; Lin Y.-F.; Tsai I.-J.; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2021-10-06T08:04:50Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; Wu V.-C.; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; Wu V.-C.; Lai T.-S.; Lin Y.-F.; I-JUNG TSAI; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2021-09-04T06:11:33Z |
Reimbursement policies in the Asia-Pacific for chronic hepatitis B
|
Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H. |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
|
Lin C.-H.; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; Huang C.-S.; ANN-LII CHENG; Lu Y.-S.; Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-08-24T02:10:13Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; Wu V.-C.; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; TAO-MIN HUANG; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
|
Yeo W.; Ueno T.; CHING-HUNG LIN; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; Lu Y.-S.; The Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-07-26T10:01:31Z |
DockCoV2: A drug database against SARS-CoV-2
|
Chen T.-F;Chang Y.-C;Hsiao Y;Lee K.-H;Hsiao Y.-C;Lin Y.-H;Tu Y.-C.E;Huang H.-C;Chen C.-Y;Juan H.-F.; Chen T.-F; Chang Y.-C; Hsiao Y; Lee K.-H; Hsiao Y.-C; Lin Y.-H; Tu Y.-C.E; Huang H.-C; Chen C.-Y; Juan H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2021-07-02T03:42:43Z |
Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes
|
Lee J.-M.; Tu C.-F.; Yang P.-W.; Lee K.-H.; Tsuji K.; Tsai M.-K.; Chen R.J.; Hu C.-Y.; Hsieh R.-P.; Tai H.-C.; BOR-LUEN CHIANG; Weng C.-N.; Lee Y.-C.; Lee C.-J. |
| 臺大學術典藏 |
2021-06-04T03:32:10Z |
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation
|
Chiang W.-F.; Cheng T.-M.; Chang C.-C.; SZU-HUA PAN; Changou C.A.; Chang T.-H.; Lee K.-H.; Wu S.-Y.; Chen Y.-F.; Chuang K.-H.; Shieh D.-B.; Chen Y.-L.; Tu C.-C.; Tsui W.-L.; Wu M.-H. |
| 臺大學術典藏 |
2021-06-02T05:43:58Z |
CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression
|
Wang S.-W.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; Tsai A.-C.; Chang Y.-L.; JIH-HWA GUH; Kuo S.-C.; Lee K.-H.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:57Z |
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo
|
Wang S.-W.; Pan S.-L.; Huang Y.-C.; JIH-HWA GUH; Chiang P.-C.; Huang D.-Y.; Kuo S.-C.; Lee K.-H.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:48Z |
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
|
Lee K.-H.; Hsu E.-C.; JIH-HWA GUH; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. |
| 臺大學術典藏 |
2021-05-31T06:18:04Z |
Cardiac glycosides from antiaris toxicaria with potent cardiotonic activity
|
Shi L.-S.; Liao Y.-R.; MING-JAI SU; Lee A.-S.; Kuo P.-C.; Damu A.G.; Kuo S.-C.; Sun H.-D.; Lee K.-H.; Wu T.-S. |
| 臺大學術典藏 |
2021-05-28T02:07:26Z |
DockCoV2: a drug database against SARS-CoV-2
|
Chen, T.-F., Chang, Y.-C., Hsiao, Y., Lee, K.-H., Hsiao, Y.-C., Lin, Y.-H., Tu, Y.-C. E., Huang, H.-C., Chen, C.-Y., Juan, H.-F.; Chen, T.-F.; Chang, Y.-C.; Hsiao, Y.; Lee, K.-H.; Hsiao, Y.-C.; Lin, Y.-H.; Tu, Y.-C. E.; Huang, H.-C.; Chen, C.-Y.; Juan, H.-F. |
| 臺大學術典藏 |
2021-04-23T05:56:32Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
|
Park K.;Vansteenkiste J.;Lee K.H.;Pentheroudakis G.;Zhou C.;Prabhash K.;Seto T.;Voon P.J.;Tan D.S.W.;Chih-Hsin Yang;Wang J.;Babu K.G.;Nakayama Y.;Alip A.;Chua K.L.M.;Cheng J.C.-H.;Senan S.;Ahn Y.C.;Kim T.-Y.;Ahn H.K.;Peters S.;Yoshino T.;Douillard J.-Y.; Park K.; Vansteenkiste J.; Lee K.H.; Pentheroudakis G.; Zhou C.; Prabhash K.; Seto T.; Voon P.J.; Tan D.S.W.; CHIH-HSIN YANG; Wang J.; Babu K.G.; Nakayama Y.; Alip A.; Chua K.L.M.; Cheng J.C.-H.; Senan S.; Ahn Y.C.; Kim T.-Y.; Ahn H.K.; Peters S.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor�VNaive ALK-Positive Non�VSmall Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
|
Camidge D.R.;Kim H.R.;Ahn M.-J.;Chih-Hsin Yang;Han J.-Y.;Hochmair M.J.;Lee K.H.;Delmonte A.;Garc?A Campelo M.R.;Kim D.-W.;Griesinger F.;Felip E.;Califano R.;Spira A.;Gettinger S.N.;Tiseo M.;Lin H.M.;Gupta N.;Hanley M.J.;Ni Q.;Zhang P.;Popat S.; Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garc?a Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.; Gettinger S.N.; Tiseo M.; Lin H.M.; Gupta N.; Hanley M.J.; Ni Q.; Zhang P.; Popat S. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu Y.-L.;Cheng Y.;Zhou J.;Lu S.;Zhang Y.;Zhao J.;Kim D.-W.;Soo R.A.;Kim S.-W.;Pan H.;Chen Y.-M.;Chian C.-F.;Liu X.;Tan D.S.W.;Bruns R.;Straub J.;Johne A.;Scheele J.;Park K.;Chih-Hsin Yang;Liu Z.;Chen X.;Wang M.;Yu S.;Zhang H.;Fang J.;Li W.;Yang C.-H.;Chang G.-C.;Hsia T.-C.;Yang C.-T.;Wang C.-C.;Cho B.C.;Lee K.H.;Kim Y.-C.;An H.J.;Woo I.S.;Cho J.Y.;Shin S.W.;Lee J.-S.;Kim J.-H.;Yoo S.S.;Kato T.;Shinagawa N.;Tan S.W.D.;Ngo L.S.-M.;Ratnavelu K.;Ahmad A.R.;Liam C.K.;De Marinis F.;Tassone P.;Molla A.I.;Calles Blanco A.;Lazaro Quintela M.E.;Felip Font E.;Dingemans A.-M.;Bui L.; Wu Y.-L.; Cheng Y.; Zhou J.; Lu S.; Zhang Y.; Zhao J.; Kim D.-W.; Soo R.A.; Kim S.-W.; Pan H.; Chen Y.-M.; Chian C.-F.; Liu X.; Tan D.S.W.; Bruns R.; Straub J.; Johne A.; Scheele J.; Park K.; CHIH-HSIN YANG; Liu Z.; Chen X.; Wang M.; Yu S.; Zhang H.; Fang J.; Li W.; Yang C.-H.; Chang G.-C.; Hsia T.-C.; Yang C.-T.; Wang C.-C.; Cho B.C.; Lee K.H.; Kim Y.-C.; An H.J.; Woo I.S.; Cho J.Y.; Shin S.W.; Lee J.-S.; Kim J.-H.; Yoo S.S.; Kato T.; Shinagawa N.; Tan S.W.D.; Ngo L.S.-M.; Ratnavelu K.; Ahmad A.R.; Liam C.K.; de Marinis F.; Tassone P.; Molla A.I.; Calles Blanco A.; Lazaro Quintela M.E.; Felip Font E.; Dingemans A.-M.; Bui L. |
| 臺大學術典藏 |
2021-04-23T05:56:25Z |
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non�Vsmall Cell Lung Cancer
|
Yu H.A.;Paz-Ares L.G.;Chih-Hsin Yang;Lee K.H.;Garrido P.;Park K.;Kim J.-H.;Lee D.H.;Mao H.;Wijayawardana S.R.;Gao L.;Hozak R.R.;Chao B.H.;Planchard D.; Yu H.A.; Paz-Ares L.G.; CHIH-HSIN YANG; Lee K.H.; Garrido P.; Park K.; Kim J.-H.; Lee D.H.; Mao H.; Wijayawardana S.R.; Gao L.; Hozak R.R.; Chao B.H.; Planchard D. |
| 臺大學術典藏 |
2021-03-15T07:59:48Z |
Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes
|
Lee J.-M.; Tu C.-F.; Yang P.-W.; Lee K.-H.; Tsuji K.; Tsai M.-K.; Chen R.J.; CHUNG-YI HU; Hsieh R.-P.; Tai H.-C.; Chiang B.-L.; Weng C.-N.; Lee Y.-C.; Lee C.-J. |
